# Neoadjuvant Therapy for Esophageal Cancer and Cardiopulmonary Physiology

> **NCT03462524** · — · COMPLETED · sponsor: **St. James's Hospital, Ireland** · enrollment: 384 (actual)

## Conditions studied

- Esophageal Cancer
- Radiation Pneumonitis
- Pulmonary Fibrosis
- Respiratory Failure
- Pneumonia
- Surgery
- Chemotherapy Effect
- Radiation Fibrosis
- Radiation Toxicity
- Adenocarcinoma
- Squamous Cell Carcinoma

## Interventions

- **PROCEDURE:** Esophagectomy

## Key facts

- **NCT ID:** NCT03462524
- **Lead sponsor:** St. James's Hospital, Ireland
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01-01
- **Primary completion:** 2016-01-01
- **Final completion:** 2018-01-01
- **Target enrollment:** 384 (ACTUAL)
- **Last updated:** 2018-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03462524

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03462524, "Neoadjuvant Therapy for Esophageal Cancer and Cardiopulmonary Physiology". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03462524. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*